Literature DB >> 19620614

MEIS1 p.R272H in familial restless legs syndrome.

C Vilariño-Güell1, H Chai, B H Keeling, J E Young, A Rajput, T Lynch, J O Aasly, R J Uitti, Z K Wszolek, M J Farrer, S-C Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19620614      PMCID： PMC2715576          DOI： 10.1212/WNL.0b013e3181ae7c79

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  Clinical practice. Restless legs syndrome.

Authors:  Christopher J Earley
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

2.  SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.

Authors:  Alexander A L Jorge; Silvia C Souza; Miriam Y Nishi; Ana E Billerbeck; Débora C C Libório; Chong A Kim; Ivo J P Arnhold; Berenice B Mendonca
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

3.  A genetic risk factor for periodic limb movements in sleep.

Authors:  Hreinn Stefansson; David B Rye; Andrew Hicks; Hjorvar Petursson; Andres Ingason; Thorgeir E Thorgeirsson; Stefan Palsson; Thordur Sigmundsson; Albert P Sigurdsson; Ingibjorg Eiriksdottir; Emilia Soebech; Donald Bliwise; Joseph M Beck; Ami Rosen; Salina Waddy; Lynn M Trotti; Alex Iranzo; Madhav Thambisetty; Gudmundur A Hardarson; Kristleifur Kristjansson; Larus J Gudmundsson; Unnur Thorsteinsdottir; Augustine Kong; Jeffrey R Gulcher; Daniel Gudbjartsson; Kari Stefansson
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245

4.  A genetic risk factor for periodic limb movements in sleep.

Authors:  Carles Vilariño-Güell; Matthew J Farrer; Siong-Chi Lin
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

5.  AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins.

Authors:  W F Shen; J C Montgomery; S Rozenfeld; J J Moskow; H J Lawrence; A M Buchberg; C Largman
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Mutation in the RIEG1 gene in patients with iridogoniodysgenesis syndrome.

Authors:  S C Kulak; K Kozlowski; E V Semina; W G Pearce; M A Walter
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

7.  Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.

Authors:  Juliane Winkelmann; Barbara Schormair; Peter Lichtner; Stephan Ripke; Lan Xiong; Shapour Jalilzadeh; Stephany Fulda; Benno Pütz; Gertrud Eckstein; Stephanie Hauk; Claudia Trenkwalder; Alexander Zimprich; Karin Stiasny-Kolster; Wolfgang Oertel; Cornelius G Bachmann; Walter Paulus; Ines Peglau; Ilonka Eisensehr; Jacques Montplaisir; Gustavo Turecki; Guy Rouleau; Christian Gieger; Thomas Illig; H-Erich Wichmann; Florian Holsboer; Bertram Müller-Myhsok; Thomas Meitinger
Journal:  Nat Genet       Date:  2007-07-18       Impact factor: 38.330
  7 in total
  10 in total

1.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 2.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

3.  Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.

Authors:  Qinbo Yang; Lin Li; Qiuyun Chen; Nancy Foldvary-Schaefer; William G Ondo; Qing Kenneth Wang
Journal:  Sleep Med       Date:  2011-09       Impact factor: 3.492

Review 4.  Animal models of RLS phenotypes.

Authors:  Richard P Allen; Nathan C Donelson; Byron C Jones; Yuqing Li; Mauro Manconi; David B Rye; Subhabrata Sanyal; Juliane Winkelmann
Journal:  Sleep Med       Date:  2016-09-02       Impact factor: 3.492

5.  BTBD9 attenuates manganese-induced oxidative stress and neurotoxicity by regulating insulin growth factor signaling pathway.

Authors:  Pan Chen; Hong Cheng; Fuli Zheng; Shaojun Li; Julia Bornhorst; Bobo Yang; Kun He Lee; Tao Ke; Yunhui Li; Tanja Schwerdtle; Xiaobo Yang; Aaron B Bowman; Michael Aschner
Journal:  Hum Mol Genet       Date:  2022-07-07       Impact factor: 5.121

6.  Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome.

Authors:  Eva C Schulte; Maria Kousi; Perciliz L Tan; Erik Tilch; Franziska Knauf; Peter Lichtner; Claudia Trenkwalder; Birgit Högl; Birgit Frauscher; Klaus Berger; Ingo Fietze; Magdolna Hornyak; Wolfgang H Oertel; Cornelius G Bachmann; Alexander Zimprich; Annette Peters; Christian Gieger; Thomas Meitinger; Bertram Müller-Myhsok; Nicholas Katsanis; Juliane Winkelmann
Journal:  Am J Hum Genet       Date:  2014-07-03       Impact factor: 11.025

7.  MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.

Authors:  Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2012-09-22       Impact factor: 3.575

Review 8.  Restless legs syndrome associated with major diseases: A systematic review and new concept.

Authors:  Claudia Trenkwalder; Richard Allen; Birgit Högl; Walter Paulus; Juliane Winkelmann
Journal:  Neurology       Date:  2016-03-04       Impact factor: 9.910

9.  Update on the management of restless legs syndrome: existing and emerging treatment options.

Authors:  Maurizio F Facheris; Andrew A Hicks; Peter P Pramstaller; Irene Pichler
Journal:  Nat Sci Sleep       Date:  2010-09-08

Review 10.  Whole genome association studies in complex diseases: where do we stand?

Authors:  Anna C Need; David B Goldstein
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.